Advertisements

Panthenol-Teva

Quick links to important sections

Panthenol-Teva

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Panthenol-Teva

Quick Facts

Property Description
Active ingredient Dexpanthenol (D-pantothenyl alcohol)
Forms Cream, Ointment, Solution, Spray
Pharmacological class Provitamin B5 / Vitamin and analogue
Common use Epithelium support and skin barrier function
Origin Synthetic derivative

What Type of Medicine is Panthenol-Teva?

Panthenol-Teva is a recognized pharmaceutical preparation featuring Dexpanthenol as its active ingredient. Dexpanthenol is a substance chemically classified as a Provitamin B5 within the vitamin and analogue therapeutic group. This agent is the stable, synthetic derivative of pantothenic acid (Vitamin B5), and it functions as a precursor that undergoes rapid enzymatic cleavage within tissues to form the biologically active vitamin.

The precursor mechanism is clinically recognized for directly supporting cellular regeneration. The preparation is confirmed to be an effective agent for maintaining skin integrity and function. Notably, Dexpanthenol is the only isomer of pantothenol that is considered biologically active for these therapeutic purposes.

Composition and Physical Forms of Dexpanthenol

The medicine is typically formulated as a single-active-ingredient product and is available in several high-level dosage forms tailored for topical (dermal) route of administration, including an ointment, a cream, a solution, and a spray. The selection of forms, from occlusive ointments to lighter solutions, allows for therapeutic application across varied affected areas. The product range is generally positioned as suitable for all general users due to the ingredient's high compatibility and low irritation potential, which is established through widespread dermatological application.

What is the General Health Purpose of Panthenol-Teva?

The core general purpose of the preparation is to support epithelium support and aid in tissue maintenance. Its role in Coenzyme A synthesis drives cell metabolism, which helps promote the accelerated process of re-epithelialization and facilitates general wound healing. Moreover, Dexpanthenol acts as an effective humectant, meaning it directly attracts and retains moisture, a mechanism that strengthens the crucial skin barrier function and enhances overall skin health.

Advertisements

What side effects are possible with Panthenol-Teva?

Possible side effects and safety information

Officially Documented Adverse Reactions

The safety profile of topical Dexpanthenol (Panthenol-Teva) is primarily defined by events affecting the Skin and Subcutaneous Tissue Disorders system, according to regulatory data. The officially listed adverse reactions are predominantly localized to the site of application and relate to hypersensitivity. These documented effects include local irritation, itching (pruritus), tingling, urticaria (hives), and various allergic reactions. Specific reports also mention instances of generalized dermatitis and localized red patches of skin.

Frequency Classification: Most adverse events reported for the topical form are classified as Frequency Not Defined in regulatory labeling. This designation reflects that the events do not fit into standard common or uncommon tiers, with some sources noting only a few reports of allergic reactions.

Serious Adverse Reactions: The most severe documented safety concern is a serious systemic allergic reaction, which may involve symptoms such as swelling of the face, tongue, or throat, difficulty breathing, wheezing, and tightness in the chest.


Population-Specific and General Safety Constraints

The preparation is strictly contraindicated for use in individuals with known hypersensitivity to any of its components.

Constraint Area Regulatory Status (High-Level)
Pregnancy Pregnancy Category C (Use only if benefit justifies potential risk)
Lactation Caution advised, as excretion into human milk is possible but not known
Administration Strictly for external use only; contact with the eyes must be avoided

These safety classifications and constraints establish the formal boundaries for the medicine’s risk profile as mandated by governmental health authorities.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for topical Dexpanthenol (Panthenol-Teva) formulations indicates that there is no documented systemic overdose syndrome resulting from excessive application to the skin. Therefore, the focus of regulatory emergency actions is centered exclusively on a specific type of exposure: potential harm following the oral route.

Element Official Regulatory Statement
Documented Overdose Presentations No specific clinical signs or symptoms of systemic overdose are formally documented for excessive topical use.
Exposure-Related Factors Primary regulatory concern is harm following accidental ingestion (swallowing) of the product.
Antidote Information No specific antidote is known or described in the official regulatory labeling for Dexpanthenol.

Emergency Actions Mandated by Regulators

In the event of accidental oral ingestion, immediate action is required. Official government labeling explicitly mandates urgent attention and defines the necessary steps:

Action Required When Immediate Medical Help is Required
Contact a Poison Control Center If the product is swallowed, help must be sought right away.
Supportive Treatment Management for this exposure is generally confined to symptomatic and supportive care, as directed by professional medical services.

The regulatory structure emphasizes that accidental swallowing, particularly by children, is the critical event that necessitates urgent intervention. This population-specific risk is addressed by the specific instruction to seek immediate assistance.

Advertisements

Therapeutic Uses of Panthenol-Teva

The preparation is used in areas where short-term symptom management is appropriate, and may assist with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities. It is applied across domains where additional symptomatic support is needed, and helps address symptom clusters that may become more noticeable.

The medicine is commonly used to help with symptoms of immediate burning, soreness, and redness associated with superficial cuts, abrasions, and minor burns or sunburn. Key indications include diaper rash and protecting chafed skin, along with managing the symptoms of chronic dryness. The use of the preparation may provide support that helps to ease the overall symptom load during healing phases.

It is relevant in conditions characterized by periods of heightened symptoms of dryness and associated irritation. It is applied when symptoms create noticeable functional strain, including manifestations like persistent roughness, scaling, tightness, and the accompanying itching (pruritus). It supports improved day-to-day comfort during symptomatic periods and may help patients cope more steadily with symptom fluctuations.


Quick Facts: Symptomatic Relief Domains

Symptom Type Common Contexts of Use Patient Benefit
Redness, burning, soreness, scaling, itching Minor burns, sunburn, diaper rash, chronic skin dryness Supports general well-being during symptomatic phases, assists with maintaining functional stability, helps improve day-to-day comfort

Regulatory References

  1. NIH DailyMed Drug Facts Label
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Panthenol-Teva?

The official eligibility profile for Panthenol-Teva (topical Dexpanthenol) is determined by regulatory documentation that establishes broad permission for use, alongside a single absolute contraindication.


Eligibility scope

Populations for whom use is allowed (as stated in label):

  • Infants, Children, Adults, and Older Adults: Use is established and permitted across all age groups. Regulatory labels specifically document use for conditions like diaper rash in infants.

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity (allergy) to the active substance, Dexpanthenol, or to any of the other ingredients (excipients) in the specific formulation.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Use is generally permitted during both pregnancy and lactation.

Eligibility-related restrictions:

  • Use is restricted on open wounds or infected skin and should be avoided unless under medical supervision.
  • If applied to the nipple area during lactation, the product must be removed/wiped off thoroughly before nursing.

Resulting eligibility structure

Official eligibility statements:

  • The medicine is contraindicated only by hypersensitivity to its components.
  • Use is established across the full age spectrum from infants to older adults.
  • Use is conditional based on the integrity of the skin and the anatomical application site during breastfeeding.

Connection to the overall eligibility profile The regulatory documents define who can use the medicine by establishing permission for the vast majority of populations. The only absolute prohibition is the allergy-based contraindication, while minor restrictions define necessary precautions for application on compromised skin or during breastfeeding, consistent with its status as a topical agent.

Advertisements

What should I know about interactions with other medicines?

The regulatory information concerning the interaction profile of Panthenol-Teva (Dexpanthenol) is primarily defined by its topical route of administration (cream, ointment, or spray). This route results in minimal systemic exposure, which serves as the interaction-context constraint in regulatory documents.


Interaction Profile and Restrictions

The official interaction profile of the topical formulation is characterized by a low risk of interaction, as regulatory bodies state that no drug interactions have been reported with its use due to its local action. This classification confirms the negligible potential for clinically significant pharmacokinetic or pharmacodynamic interactions with other medicines, food, alcohol, or herbal products when applied topically. Consequently, the regulatory labeling does not include mandatory timing-separation rules or restrictions for co-administration.

Route-Specific Pharmacodynamic Interaction

A specific pharmacodynamic interaction is documented, but it is exclusively linked to the parenteral (injection/systemic) route of the active ingredient. Co-administration of the Dexpanthenol injection with the neuromuscular blocking agent succinylcholine has been officially documented to result in a prolongation of succinylcholine's effects. Related to this systemic interaction, regulatory instructions specify that the injection form of Dexpanthenol should not be administered within one hour of succinylcholine. There are no population-specific interaction notes, such as increased severity in hepatic or renal impairment, explicitly detailed in the regulatory labeling for the topical product.

Advertisements

Mechanism of Action

Panthenol (Dexpanthenol) is the alcohol analog of pantothenic acid (vitamin B5) and functions as a pro-vitamin that is rapidly converted into the biologically active compound upon absorption.


Coenzyme A Synthesis and Cellular Metabolism

This domain covers Panthenol's role as a precursor in the production of Coenzyme A (CoA), a key cofactor for numerous enzymatic reactions. Once converted to pantothenic acid within cells, it becomes essential for metabolic pathways involving the synthesis and breakdown of fatty acids, proteins, and carbohydrates. This central role in cell metabolism provides necessary precursor for processes supporting epithelial cell proliferation.


Modulation of Skin Barrier Function

This mechanistic domain involves Panthenol's capacity to directly influence the outermost layer of the skin, the stratum corneum. Its hygroscopic (water-attracting) properties act as a humectant, significantly increasing the stratum corneum's water content. This increased hydration modifies the molecular arrangement of stratum corneum lipids and proteins, which results in decreased transepidermal water flux and altered mechanical properties of the stratum corneum.


Influence on Epithelial Remodeling

The mechanism here is the downstream effect of increased CoA availability on cell processes. Panthenol increases fibroblast proliferation and the rate of re-epithelialization and granulation tissue formation. This modulation of cell kinetics influences the physiological process of superficial tissue remodeling.

Advertisements

Dosage and Administration Information

Administration Scope

The administration of Panthenol-Teva, which contains Dexpanthenol, is defined for external use only via the Topical (Dermal) route. Available forms include creams, ointments, solutions, and sprays, with the 5% concentration being a standard strength for skin protectant purposes.


Dosing, Frequency, and Procedural Conditions

Standard procedural requirements relate to application. Before the product is applied, the affected skin area must first be cleansed and allowed to dry completely. The dosing principle is defined by liberal application, where a thin layer of the product is applied to cover the entire affected surface.

The dosing schedule is structured around necessity, classifying its use as an as-needed (Intermittent) pattern. Frequency instructions specify that the product should be applied as often as necessary to the symptomatic area. For applications requiring specific timing, such as in the pediatric context, instructions include application with each diaper change and particularly at bedtime or when prolonged exposure to moisture is anticipated. The regimen does not include fixed systemic schedules or missed-dose rules, as it is applied solely based on need.


Connection to the Overall Use Protocol

These instructions define the use of the medicine as a strictly topical administration protocol that requires pre-application preparation of the skin. The protocol emphasizes the as-needed frequency and the liberal application of the product, establishing the standardized, intermittent administration of the medicine.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase 3 Trials: Pain Management in Cancer

Studies evaluated the properties of this drug in individuals experiencing moderate to severe pain in cancer patients. Research examined the associations observed between treatment and pain levels and quality of life. Clinical trials documented observations of pain severity over time.

Clinical trials evaluated the time to onset of pain-related changes.

A Phase 3 study evaluated whether the use of the drug was associated with a change in the reported need for rescue medication.


Combination Therapy Research

Research evaluated the data collected from combination therapy involving the drug and reported on the speed of observed changes. The trials documented data regarding the combined tolerability profile.

Some trials included comparisons of this drug to other pain management options. These comparisons were part of the investigation into the drug’s different profiles.


Patient Subgroups and Dosage

Chronic Non-Cancer Pain

Studies have also investigated the use of this drug in individuals experiencing chronic non-cancer pain. Findings in this population have been more limited. Research in this population documented findings related to the drug's tolerability.

Geriatric Population

Studies examined the tolerability of the drug among different age groups, including the elderly. Trial protocols documented how reported side effects in this population were assessed in comparison to younger cohorts.

Dosing Strategies

Research protocols documented the investigation of various dosing strategies, including a low starting dose. The research collected data on the reported differences in pain and side effects across various doses.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Panthenol-Teva (FAQ)

Q: What is the main difference between Panthenol-Teva and a regular moisturizer?

Panthenol-Teva is classified as a pharmaceutical preparation that contains the active ingredient Dexpanthenol, a Provitamin B5. While it does act as a humectant to attract and retain moisture (like a regular moisturizer), the product's function includes supporting key cellular processes. This involves supporting epithelial cell proliferation and re-epithelialization, which aids in tissue maintenance and recovery.

Q: Why is Panthenol-Teva sometimes referred to by a different name?

The drug may be referenced by different names because its active substance is Dexpanthenol (D-pantothenyl alcohol). This ingredient is a synthetic derivative of pantothenic acid, which is commonly known as Vitamin B5. Therefore, regulatory and scientific sources may refer to it by its generic name (Dexpanthenol) or its chemical classification (Provitamin B5).

Q: Is Panthenol-Teva considered an antibiotic?

No, according to official classification, Panthenol-Teva is not an antibiotic. It is classified within the vitamin and analogue therapeutic group as a Provitamin B5. Its core general purpose is to support epithelium function and tissue maintenance, not to provide antimicrobial action.

Q: Why do official documents mention that Panthenol-Teva is for 'minor' issues?

Studies indicate that the active ingredient, Dexpanthenol, is frequently examined and utilized for the treatment of superficial skin injuries. The mechanism of the active ingredient supports re-epithelialization, which is beneficial for minor skin issues. These may include abrasions, mild burns, and dry or chapped skin.

Q: If I accidentally get Panthenol-Teva in my eye, what is the recommended first aid?

Official labeling notes that contact with the eyes should be avoided as the preparation is only for external dermal use. If accidental contact with the eye occurs, the general safety instruction is to immediately rinse the area thoroughly with water. If irritation persists or symptoms worsen, contact a healthcare professional.

Q: Is Panthenol-Teva available without a prescription?

Yes. Topical formulations of Dexpanthenol, such as Panthenol-Teva, are widely classified by regulatory bodies in the United States and many other jurisdictions as an Over-the-Counter (OTC) product. This classification means it is legally available for general public use without a prescription.

Q: Can Panthenol-Teva be used alongside products that contain retinol?

According to the official regulatory profile for this topical product, no drug-to-drug interactions have been reported. This is due to the medicine's local action and minimal systemic absorption. While specific interactions with topical cosmetic ingredients like retinol are not formally addressed in drug labels, the low potential for interaction is noted.

Q: Does using Panthenol-Teva make skin more sensitive to the sun?

Regulatory documents do not list increased photosensitivity as a reported adverse effect of the active ingredient Dexpanthenol itself. However, it is generally recommended that users follow general sun safety guidelines when using any topical product, as specific formulations may vary.

Q: Are there any dietary restrictions mentioned in official literature while using Panthenol-Teva?

No specific dietary restrictions are noted in the regulatory documents for the topical use of this product. Official labeling states that no interactions have been reported with food, alcohol, or herbal products. This confirms the negligible risk for interaction with common dietary elements.

Q: Why is Panthenol-Teva sometimes used after cosmetic procedures?

Studies indicate that Dexpanthenol is often utilized following superficial skin injuries like those resulting from procedures such as laser treatment or dermabrasion. The ingredient may help support the process of re-epithelialization and aids in restoring the damaged skin barrier function.

Q: What happens if I stop using Panthenol-Teva suddenly?

The regulatory protocol for this topical product defines its use as an 'as-needed' or intermittent pattern. Because it does not have fixed systemic schedules or a dependency profile, no specific withdrawal procedures are documented. Official information does not record any specific negative consequences for discontinuation.

Q: Does Panthenol-Teva interact with topical products containing salicylic acid?

Regulatory documents state that no drug interactions have been reported with the topical use of Dexpanthenol, which is attributed to its local action. This suggests a low potential for clinically significant interactions. Specific interactions with other cosmetic topical ingredients like salicylic acid are not typically detailed in general drug labels.

Q: Is Panthenol-Teva a vegan product?

The active ingredient, Dexpanthenol, is a synthetic derivative. However, regulatory bodies do not provide a 'vegan' classification for the final product. This status depends on the source and processing of the inactive ingredients (excipients) in the specific formulation, which are subject to individual regulatory compliance.

Q: What is the legal classification of Panthenol-Teva in different countries (e.g., OTC vs. Prescription)?

Topical Dexpanthenol, the active ingredient in Panthenol-Teva, is widely classified as an Over-the-Counter (OTC) medicine. This is the established regulatory classification across the US, Canada, and many European jurisdictions, allowing for public access without a prescription.

Q: Can Panthenol-Teva be used by people with known heart conditions?

Due to its strictly topical application and minimal systemic absorption, official regulatory labels do not document specific warnings, contraindications, or dose adjustments for people with pre-existing heart conditions. The drug’s safety profile is limited primarily to localized effects at the site of application.

Q: Is Panthenol-Teva safe to use during dental procedures or on oral tissues?

Regulatory guidelines specify that topical dermal application of Panthenol-Teva is for external use only. However, the active ingredient Dexpanthenol is used in separate, approved formulations for mucosal tissues, such as certain mouthwashes.

Q: What is the role of the inactive ingredients in the Panthenol-Teva formulation?

The inactive ingredients, or excipients, are included in the product to ensure proper stability, consistency, and texture for application, such as preservatives or emulsifiers. They are noted in regulatory information primarily to caution individuals with known hypersensitivity to any of those specific components.

Q: How does Panthenol-Teva work when applied to hair or the scalp?

While the product is officially approved for dermal use, Dexpanthenol is commonly found in hair care products. Research suggests its Provitamin B5 mechanism is associated with supporting the hair shaft and cell viability in hair follicle cells. This is consistent with its tissue-supporting mechanism.

Q: Are there specific official warnings for people with respiratory conditions?

The most serious safety concern documented is a systemic allergic reaction, which can involve severe respiratory symptoms like wheezing, difficulty breathing, and tightness in the chest. If signs of a systemic allergic reaction occur, official labels instruct that immediate medical attention is necessary.

Q: Can Panthenol-Teva be used on skin that has been tattooed?

Studies indicate that topical Dexpanthenol is often used for tattoo aftercare. Its use on newly tattooed skin has been examined and may assist in moisturizing the skin barrier and supporting the healing process.

Q: Does Panthenol-Teva contain any parabens or common preservatives?

The inclusion of specific excipients, such as parabens or common preservatives, depends entirely on the specific product formulation. While not detailed in general drug labeling, all excipients used must meet national and international safety regulations concerning their use in pharmaceutical products.

Q: Why is Panthenol-Teva often included in first aid kits?

It is widely included in first aid kits because of its core official purpose, which is to support the skin’s epithelium and aid in the process of re-epithelialization and wound healing. This makes it a suitable topical preparation for managing minor cuts, scrapes, and burns commonly encountered in first aid situations.

Q: Can Panthenol-Teva be used on the face?

The product is for topical, external use on the affected skin area. While official labeling mandates that it must be kept out of the eyes and sensitive mucosal areas, there is no specific restriction in official documents prohibiting its use on the skin of the face.

Q: Is Panthenol-Teva safe to use for sensitive skin?

Official labeling describes the ingredient as generally well-tolerated with low irritation potential due to its local action. Officially documented side effects are primarily limited to localized irritation or allergic reactions in sensitive individuals. The product is considered suitable for broad application.

Q: Are there any ingredients in Panthenol-Teva that commonly cause allergic reactions?

Official guidance states the product is strictly contraindicated only in individuals with known hypersensitivity (allergy) to Dexpanthenol or to any other ingredients (excipients). If any signs of an allergic reaction appear, official instructions are to immediately discontinue use.

Q: Is Panthenol-Teva suitable for use on broken skin?

Use is restricted on open wounds or infected skin and should only be applied in these cases under medical supervision. However, the product is intended to promote re-epithelialization for conditions involving minor skin breaks, abrasions, or chapping.

Q: What are some common misunderstandings about how Panthenol-Teva should be applied?

One common point of clarification relates to the application schedule. Official instructions define use as an 'as-needed' or intermittent pattern. This means it is applied liberally only when necessary to the symptomatic area, not under a fixed, systemic dosing schedule.

Q: Is there a maximum amount of time Panthenol-Teva is intended to be used?

Regulatory documentation defines the dosing schedule as being based on necessity, meaning an as-needed (intermittent) pattern. Consequently, official sources do not establish a fixed systemic schedule or specify a maximum duration for continuous use of the topical product.

Q: Is Panthenol-Teva considered a steroid?

No. According to regulatory documents, Panthenol-Teva (Dexpanthenol) is chemically classified as a Provitamin B5, which is part of the vitamin and analogue therapeutic group. It is not classified as a steroid or corticosteroid.

Q: What is the difference between Panthenol-Teva cream and Panthenol-Teva ointment, if both exist?

Both dosage forms contain the same active ingredient (Dexpanthenol). The primary difference is based on the inactive ingredients, which determine the product’s physical properties. Ointments are generally designed to be more occlusive (forming a protective barrier) while creams are typically lighter and less greasy.

Q: Are there specific body areas where Panthenol-Teva should not be applied?

Yes. The preparation is strictly for external dermal use. Official guidelines state that contact with the eyes, open wounds, and infected skin should be avoided. Additionally, if the product is applied to the nipple area during lactation, it must be thoroughly removed prior to nursing.

Q: Is there a risk of overdose or using too much Panthenol-Teva topically?

The dosing principle is defined by ‘liberal application’ to cover the affected area. Official documents do not list risks of systemic overdose due to topical use, as the product exhibits minimal systemic absorption.

Advertisements

How should Panthenol-Teva be stored and disposed of?

How to Store and Dispose of Panthenol-Teva

Official regulatory labeling dictates strict conditions for storing Panthenol-Teva to ensure the product's stability. The medicine must be stored at a temperature not exceeding 30 C (or 25 C for certain formulations) and should be protected from light. The container, such as the cream tube, must be kept tightly closed when not in use.

Stability and Safety

  • After Opening: The product has a limited shelf-life and must be used within one month (30 days) after the initial opening.
  • Child Safety: Panthenol-Teva is required to be stored out of the sight and reach of children.
  • Disposal: The medicine must not be applied after the expiration date. For disposal of any unused or expired product, consult with a pharmacist or local waste disposal service, as no special hazardous waste handling instructions are typically documented for this topical cream.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panthenol-Teva found in:

A-Z Index: